Geographic Variations and the Associated Factors in Adherence to and Persistence with Adjuvant Hormonal Therapy for the Privately Insured women Aged 18–64 with Breast Cancer in Texas
Current Oncology · 2023
DOI: 10.3390/curroncol30040288 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2023. Verfasst von Junghyun Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine, College of Medicine, Yonsei University, Seoul 03722, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Kyung Hee University.
Abstract (Originalsprache)
The purpose of this study is to examine the geographical patterns of adjuvant hormonal therapy adherence and persistence and the associated factors in insured Texan women aged 18–64 with early breast cancer. A retrospective cohort study was conducted using 5-year claims data for the population insured by the Blue Cross Blue Shield of Texas (BCBSTX). Women diagnosed with early breast cancer who were taking tamoxifen or aromatase inhibitors (AIs) for adjuvant hormonal therapy with at least one prescription claim were identified. Adherence to adjuvant hormonal therapy and persistence with adjuvant hormonal therapy were calculated as outcome measures. Women without a gap between two consecutively dispensed prescriptions of at least 90 days were considered to be persistently taking the medications. Patient-level multivariate logistic regression models with repeated regional-level adjustments and a Cox proportional hazards model with mixed effects were used to determine the geographical variations and patient-, provider-, and area-level factors that were associated with adjuvant hormonal therapy adherence and persistence. Of the 938 women in the cohort, 627 (66.8%) initiated adjuvant hormonal therapy. Most of the smaller HRRs have significantly higher or lower rates of treatment adherence and persistence rates relative to the median regions. The use of AHT varies substantially from one geographical area to another, especially for adherence, with an approximately two-fold difference between the lowest and highest areas, and area-level factors were found to be significantly associated with the compliance of AHT. There are geographical variations in AHT adherence and persistence in Texas. Patient-level and area-level factors have significant associations explaining these patterns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Preventive Medicine, College of Medicine, Yonsei University, Seoul 03722, Republic of Korea.
- Clinical Research Institute, Kyung Hee University Hospital at Gangdong, School of Medicine, Kyung Hee University, Seoul 05278, Republic of Korea.
- Department of Management, Policy & Community Health, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
- Department of Epidemiology, Human Genetics & Environmental Sciences, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
- Department of Health Services Administration, School of Public Health, University of Maryland, College Park, MD 20742, USA.
- Department of Ophthalmology, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul 05278, Republic of Korea.
ORCID-Profile: Man S Kim, Xianglin L Du
Förderung
- National Research Foundation of Korea
- Kyung Hee University
Zitieren
APA
Kim, J., Kim, M. S., Rajan, S. S., Du, X. L., Franzini, L., Kim, T. G., Giordano, S. H., & Morgan, R. O. (2023). Geographic Variations and the Associated Factors in Adherence to and Persistence with Adjuvant Hormonal Therapy for the Privately Insured women Aged 18–64 with Breast Cancer in Texas. Current Oncology. https://doi.org/10.3390/curroncol30040288
Vancouver
Kim J, Kim MS, Rajan SS, Du XL, Franzini L, Kim TG, et al. Geographic Variations and the Associated Factors in Adherence to and Persistence with Adjuvant Hormonal Therapy for the Privately Insured women Aged 18–64 with Breast Cancer in Texas. Current Oncology. 2023. doi:10.3390/curroncol30040288
BibTeX
@article{Kim2023,
author = {Kim, Junghyun and Kim, Man S and Rajan, Suja S and Du, Xianglin L and Franzini, Luisa and Kim, Tae Gi and Giordano, Sharon H and Morgan, Robert O},
title = {Geographic Variations and the Associated Factors in Adherence to and Persistence with Adjuvant Hormonal Therapy for the Privately Insured women Aged 18–64 with Breast Cancer in Texas},
journal = {Current Oncology},
year = {2023},
doi = {10.3390/curroncol30040288}
}
EUVIMED